Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Improving Postpartum Follow up in Women With a Gestational Diabetes-Affected Pregnancy, Potential Extramural Project (PEP) 2008-R-02, 34023 [E8-13491]

Download as PDF Federal Register / Vol. 73, No. 116 / Monday, June 16, 2008 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Evaluation of Breastfeeding Promotion and Support Programs for African-American Women, Potential Extramural Project 2008–R–25 Correction: This notice was published in the Federal Register on April 18, 2008, Volume 73, Number 76, page 21138. The aforementioned meeting has been rescheduled to the following: Time and Date: 1:00 p.m.–3:00 p.m., June 19, 2008 (Closed). Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road NE., Mailstop E21, Atlanta, GA 30333. Telephone (404) 498–1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13472 Filed 6–13–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention rwilkins on PROD1PC63 with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Promoting Awareness of Birth Defects Prevention, Potential Extramural Project 2008–R–14 Correction: This notice was published in the Federal Register on April 16, 2008, Volume 73, Number 74, page 20679. The aforementioned meeting has been rescheduled to the following: Time and Date: 1 p.m.–3 p.m., June 19, 2008 (Closed). Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., VerDate Aug<31>2005 18:44 Jun 13, 2008 Jkt 214001 Mailstop E21, Atlanta, GA 30333. Telephone (404) 498–1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13488 Filed 6–13–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Improving Postpartum Follow up in Women With a Gestational Diabetes-Affected Pregnancy, Potential Extramural Project (PEP) 2008–R–02 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time And Date: 1 p.m.–3 p.m., June 18, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. This notice was published in the Federal Register on April 16, 2008, Volume 73, Number 74, page 20677. Additional time is required to complete the review of all applications submitted for this PEP. Applications being reviewed at the June 18, 2008, meeting will be reviewed by the same members of the original panel. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Improving Postpartum Follow up in Women with a Gestational DiabetesAffected Pregnancy, PEP 2008–R–02.’’ The National Center for Health Marketing determines that agency business requires its consideration of this matter on less than 15 days’ notice to the public and that no earlier notice of this meeting was possible. Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404) 498– 1194. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 34023 The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–13491 Filed 6–13–08; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Type-2 Diabetes Prevention in Women with a Recent History of Gestational Diabetes Mellitus, Potential Extramural Project (PEP) 2008–R–04 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 1 p.m.–4 p.m., June 18, 2008 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. This notice was published in the Federal Register on April 17, 2008, Volume 73, Number 75, page 20927. Additional time is required to complete the review of all applications submitted for this PEP. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Type-2 Diabetes Prevention in Women with a Recent History of Gestational Diabetes Mellitus, PEP 2008–R–04.’’ The National Center for Health Marketing determines that agency business requires its consideration of this matter on less than 15 days notice to the public and that no earlier notice of the meeting was possible. Contact Person for More Information: Linda Shelton, Program Specialist, Coordinating Center for Health and Information Service, Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, Atlanta, GA 30333, Telephone (404)498– 1194. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. E:\FR\FM\16JNN1.SGM 16JNN1

Agencies

[Federal Register Volume 73, Number 116 (Monday, June 16, 2008)]
[Notices]
[Page 34023]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-13491]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Improving Postpartum Follow up in Women With a 
Gestational Diabetes-Affected Pregnancy, Potential Extramural Project 
(PEP) 2008-R-02

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time And Date: 1 p.m.-3 p.m., June 18, 2008 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463. This notice 
was published in the Federal Register on April 16, 2008, Volume 73, 
Number 74, page 20677. Additional time is required to complete the 
review of all applications submitted for this PEP. Applications 
being reviewed at the June 18, 2008, meeting will be reviewed by the 
same members of the original panel.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Improving Postpartum Follow up in 
Women with a Gestational Diabetes-Affected Pregnancy, PEP 2008-R-
02.''
    The National Center for Health Marketing determines that agency 
business requires its consideration of this matter on less than 15 
days' notice to the public and that no earlier notice of this 
meeting was possible.
    Contact Person for More Information: Linda Shelton, Program 
Specialist, Coordinating Center for Health and Information Service, 
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21, 
Atlanta, GA 30333, Telephone (404) 498-1194.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: June 9, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E8-13491 Filed 6-13-08; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.